Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 28, 2020	Jun. 30, 2019	Jun. 28, 2020	Jun. 30, 2019
Sales by segment of business
Sales to customers	$ 18,336	$ 20,562	$ 39,027	$ 40,583
Percent Change (as a percent)	(10.80%)		(3.80%)
U.S.
Sales by segment of business
Sales to customers	$ 9,539	10,403	$ 20,238	20,532
Percent Change (as a percent)	(8.30%)		(1.40%)
International
Sales by segment of business
Sales to customers	$ 8,797	10,159	$ 18,789	20,051
Percent Change (as a percent)	(13.40%)		(6.30%)
Consumer Health*
Sales by segment of business
Sales to customers	$ 3,296	3,544	$ 6,921	$ 6,862
Percent Change (as a percent)	(7.00%)			0.90%
Consumer Health* | U.S.
Sales by segment of business
Sales to customers	$ 1,557	1,537	3,297	$ 2,975
Percent Change (as a percent)	1.30%			10.80%
Consumer Health* | International
Sales by segment of business
Sales to customers	$ 1,739	2,007	3,624	$ 3,887
Percent Change (as a percent)	(13.40%)			(6.80%)
Consumer Health* | Baby Care
Sales by segment of business
Sales to customers	$ 356	443	717	$ 837
Percent Change (as a percent)	(19.70%)			(14.30%)
Consumer Health* | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 96	99	$ 188	$ 186
Percent Change (as a percent)	(3.50%)		1.20%
Consumer Health* | Baby Care | International
Sales by segment of business
Sales to customers	$ 260	344	$ 529	$ 651
Percent Change (as a percent)	(24.30%)			(18.70%)
Consumer Health* | Oral Care
Sales by segment of business
Sales to customers	$ 397	389	792	$ 756
Percent Change (as a percent)	2.20%			4.80%
Consumer Health* | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 170	155	346	$ 306
Percent Change (as a percent)	9.70%			12.90%
Consumer Health* | Oral Care | International
Sales by segment of business
Sales to customers	$ 227	234	446	$ 450
Percent Change (as a percent)	(2.80%)			(0.80%)
Consumer Health* | OTC
Sales by segment of business
Sales to customers	$ 1,149	1,064	2,497	$ 2,151
Percent Change (as a percent)	7.90%			16.10%
Consumer Health* | OTC | U.S.
Sales by segment of business
Sales to customers	$ 627	484	1,316	$ 991
Percent Change (as a percent)	29.60%			32.80%
Consumer Health* | OTC | International
Sales by segment of business
Sales to customers	$ 522	580	1,181	$ 1,160
Percent Change (as a percent)	(10.10%)			1.80%
Consumer Health* | Skin Health/Beauty
Sales by segment of business
Sales to customers	$ 1,007	1,202	2,124	$ 2,292
Percent Change (as a percent)	(16.20%)			(7.30%)
Consumer Health* | Skin Health/Beauty | U.S.
Sales by segment of business
Sales to customers	$ 536	663	1,195	$ 1,251
Percent Change (as a percent)	(19.20%)			(4.50%)
Consumer Health* | Skin Health/Beauty | International
Sales by segment of business
Sales to customers	$ 471	539	929	$ 1,041
Percent Change (as a percent)	(12.50%)			(10.70%)
Consumer Health* | Women's Health
Sales by segment of business
Sales to customers	$ 202	253	434	$ 478
Percent Change (as a percent)	(20.10%)			(9.30%)
Consumer Health* | Women's Health | U.S.
Sales by segment of business
Sales to customers	$ 3	3	7	$ 6
Percent Change (as a percent)	(2.90%)			14.30%
Consumer Health* | Women's Health | International
Sales by segment of business
Sales to customers	$ 199	250	427	$ 472
Percent Change (as a percent)	(20.40%)			(9.60%)
Consumer Health* | Wound Care/Other
Sales by segment of business
Sales to customers	$ 185	193	356	$ 348
Percent Change (as a percent)	(4.00%)			2.60%
Consumer Health* | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 126	132	245	$ 234
Percent Change (as a percent)	(4.70%)			4.70%
Consumer Health* | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 59	61	111	$ 114
Percent Change (as a percent)	(2.40%)			(1.90%)
PHARMACEUTICAL
Sales by segment of business
Sales to customers	$ 10,752	10,529	$ 21,886	$ 20,773
Percent Change (as a percent)	2.10%		5.40%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales to customers	$ 6,120	5,783	$ 12,181	11,365
Percent Change (as a percent)	5.80%		7.20%
PHARMACEUTICAL | International
Sales by segment of business
Sales to customers	$ 4,632	4,746	$ 9,705	9,408
Percent Change (as a percent)	(2.40%)		3.20%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales to customers	$ 3,523	3,466	$ 7,161	6,717
Percent Change (as a percent)	1.60%		6.60%
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,362	2,379	$ 4,772	4,542
Percent Change (as a percent)	(0.70%)		5.10%
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales to customers	$ 1,161	1,087	$ 2,389	2,175
Percent Change (as a percent)	6.80%		9.80%
PHARMACEUTICAL | Immunology | REMICADE®
Sales by segment of business
Sales to customers	$ 935	1,107	$ 1,925	2,209
Percent Change (as a percent)	(15.50%)		(12.90%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S.
Sales by segment of business
Sales to customers	$ 593	801	$ 1,218	1,575
Percent Change (as a percent)	(25.80%)		(22.70%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports
Sales by segment of business
Sales to customers	$ 133	62	$ 243	138
Percent Change (as a percent)			75.70%
PHARMACEUTICAL | Immunology | REMICADE® | International
Sales by segment of business
Sales to customers	$ 208	244	$ 464	496
Percent Change (as a percent)	(14.50%)		(6.40%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®
Sales by segment of business
Sales to customers	$ 546	563	$ 1,075	1,087
Percent Change (as a percent)	(3.00%)		(1.10%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.
Sales by segment of business
Sales to customers	$ 256	281	$ 528	544
Percent Change (as a percent)	(8.70%)		(2.90%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International
Sales by segment of business
Sales to customers	$ 289	282	$ 547	543
Percent Change (as a percent)	2.60%		0.80%
PHARMACEUTICAL | Immunology | STELARA®
Sales by segment of business
Sales to customers	$ 1,697	1,558	$ 3,516	2,963
Percent Change (as a percent)	8.90%		18.70%
PHARMACEUTICAL | Immunology | STELARA® | U.S.
Sales by segment of business
Sales to customers	$ 1,138	1,058	$ 2,355	1,940
Percent Change (as a percent)	7.50%		21.40%
PHARMACEUTICAL | Immunology | STELARA® | International
Sales by segment of business
Sales to customers	$ 558	499	$ 1,161	1,022
Percent Change (as a percent)	11.90%		13.60%
PHARMACEUTICAL | Immunology | TREMFYA®
Sales by segment of business
Sales to customers	$ 342	235	$ 638	452
Percent Change (as a percent)	45.40%		41.10%
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.
Sales by segment of business
Sales to customers	$ 241	176	$ 428	344
Percent Change (as a percent)	36.70%		24.40%
PHARMACEUTICAL | Immunology | TREMFYA® | International
Sales by segment of business
Sales to customers	$ 101	59	$ 210	108
Percent Change (as a percent)	71.00%		94.00%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 3	3	$ 6	6
Percent Change (as a percent)	11.80%		2.70%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 3	3	$ 6	6
Percent Change (as a percent)	11.80%		2.70%
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales to customers	$ 878	862	$ 1,798	1,708
Percent Change (as a percent)	1.90%		5.30%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 416	387	$ 852	744
Percent Change (as a percent)	7.40%		14.50%
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 463	475	$ 946	964
Percent Change (as a percent)	(2.50%)		(1.80%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine
Sales by segment of business
Sales to customers	$ 256	210	$ 480	421
Percent Change (as a percent)	22.20%		14.10%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 10	12	$ 22	24
Percent Change (as a percent)	(14.00%)		(6.90%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International
Sales by segment of business
Sales to customers	$ 246	198	$ 458	397
Percent Change (as a percent)	24.50%		15.40%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
Sales by segment of business
Sales to customers	$ 510	535	$ 1,089	1,058
Percent Change (as a percent)	(4.70%)		2.90%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.
Sales by segment of business
Sales to customers	$ 379	344	$ 775	659
Percent Change (as a percent)	10.50%		17.70%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International
Sales by segment of business
Sales to customers	$ 130	191	$ 314	399
Percent Change (as a percent)	(32.00%)		(21.40%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales to customers	$ 113	117	$ 229	229
Percent Change (as a percent)	(4.20%)		(0.20%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales to customers	$ 25	31	$ 54	61
Percent Change (as a percent)	(18.70%)		(11.20%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales to customers	$ 87	86	$ 174	168
Percent Change (as a percent)	1.00%		3.80%
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales to customers	$ 1,587	1,538	$ 3,245	3,167
Percent Change (as a percent)	3.20%		2.50%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 778	664	$ 1,526	1,387
Percent Change (as a percent)	17.40%		10.10%
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales to customers	$ 809	875	$ 1,719	1,780
Percent Change (as a percent)	(7.60%)		(3.50%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate
Sales by segment of business
Sales to customers	$ 149	137	$ 320	351
Percent Change (as a percent)	8.70%		(8.90%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 55	15	$ 107	112
Percent Change (as a percent)			(4.20%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International
Sales by segment of business
Sales to customers	$ 94	123	$ 212	239
Percent Change (as a percent)	(23.00%)		(11.00%)
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
Sales by segment of business
Sales to customers	$ 879	818	$ 1,762	1,608
Percent Change (as a percent)	7.50%		9.50%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.
Sales by segment of business
Sales to customers	$ 576	506	$ 1,120	989
Percent Change (as a percent)	13.80%		13.20%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International
Sales by segment of business
Sales to customers	$ 303	312	$ 642	619
Percent Change (as a percent)	(2.80%)		3.70%
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®
Sales by segment of business
Sales to customers	$ 153	182	$ 323	361
Percent Change (as a percent)	(15.90%)		(10.50%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.
Sales by segment of business
Sales to customers	$ 74	81	$ 150	158
Percent Change (as a percent)	(9.30%)		(4.90%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International
Sales by segment of business
Sales to customers	$ 79	101	$ 173	203
Percent Change (as a percent)	(21.20%)		(14.90%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 406	401	$ 841	847
Percent Change (as a percent)	1.20%		(0.70%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 75	62	$ 150	128
Percent Change (as a percent)	21.50%		16.80%
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 331	340	$ 691	719
Percent Change (as a percent)	(2.50%)		(3.90%)
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales to customers	$ 2,791	2,697	$ 5,804	5,215
Percent Change (as a percent)	3.50%		11.30%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,181	1,013	$ 2,356	1,975
Percent Change (as a percent)	16.60%		19.30%
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales to customers	$ 1,609	1,684	$ 3,448	3,240
Percent Change (as a percent)	(4.40%)		6.40%
PHARMACEUTICAL | Oncology | DARZALEX®
Sales by segment of business
Sales to customers	$ 901	774	$ 1,838	1,403
Percent Change (as a percent)	16.30%		31.00%
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.
Sales by segment of business
Sales to customers	$ 492	369	$ 955	721
Percent Change (as a percent)	32.90%		32.30%
PHARMACEUTICAL | Oncology | DARZALEX® | International
Sales by segment of business
Sales to customers	$ 409	405	$ 883	682
Percent Change (as a percent)	1.20%		29.60%
PHARMACEUTICAL | Oncology | ERLEADA [Member]
Sales by segment of business
Sales to customers	$ 170	69	$ 313	130
PHARMACEUTICAL | Oncology | ERLEADA [Member] | U.S.
Sales by segment of business
Sales to customers	136	62	255	120
PHARMACEUTICAL | Oncology | ERLEADA [Member] | International
Sales by segment of business
Sales to customers	33	7	57	10
PHARMACEUTICAL | Oncology | IMBRUVICA®
Sales by segment of business
Sales to customers	$ 949	831	$ 1,980	1,615
Percent Change (as a percent)	14.10%		22.60%
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.
Sales by segment of business
Sales to customers	$ 447	367	$ 879	716
Percent Change (as a percent)	21.50%		22.60%
PHARMACEUTICAL | Oncology | IMBRUVICA® | International
Sales by segment of business
Sales to customers	$ 502	463	$ 1,101	898
Percent Change (as a percent)	8.30%		22.60%
PHARMACEUTICAL | Oncology | VELCADE®
Sales by segment of business
Sales to customers	$ 98	224	$ 206	487
Percent Change (as a percent)	(56.10%)		(57.70%)
PHARMACEUTICAL | Oncology | VELCADE® | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Oncology | VELCADE® | International
Sales by segment of business
Sales to customers	$ 98	224	$ 206	487
Percent Change (as a percent)	(56.10%)		(57.70%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate
Sales by segment of business
Sales to customers	$ 568	698	$ 1,258	1,377
Percent Change (as a percent)	(18.60%)		(8.60%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 87	198	$ 226	383
Percent Change (as a percent)	(55.60%)		(40.90%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 480	500	$ 1,032	994
Percent Change (as a percent)	(3.90%)		3.80%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 106	101	$ 210	203
Percent Change (as a percent)	5.50%		3.40%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 20	16	$ 42	34
Percent Change (as a percent)	22.90%		21.40%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 87	85	$ 169	169
Percent Change (as a percent)	2.20%		(0.30%)
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 789	690	$ 1,534	1,346
Percent Change (as a percent)	14.20%		13.90%
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 545	439	$ 1,031	869
Percent Change (as a percent)	24.20%		18.70%
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 243	251	$ 503	477
Percent Change (as a percent)	(3.30%)		5.30%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®
Sales by segment of business
Sales to customers	$ 406	348	$ 795	654
Percent Change (as a percent)	16.50%		21.60%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.
Sales by segment of business
Sales to customers	$ 256	203	$ 485	375
Percent Change (as a percent)	26.10%		29.30%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International
Sales by segment of business
Sales to customers	$ 150	146	$ 310	279
Percent Change (as a percent)	3.00%		11.20%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®
Sales by segment of business
Sales to customers	$ 282	203	$ 532	401
Percent Change (as a percent)	39.00%		32.70%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.
Sales by segment of business
Sales to customers	$ 254	175	$ 466	351
Percent Change (as a percent)	44.50%		32.60%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International
Sales by segment of business
Sales to customers	$ 28	28	$ 66	50
Percent Change (as a percent)	4.00%		33.60%
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION
Sales by segment of business
Sales to customers	$ 101	140	$ 207	292
Percent Change (as a percent)	(27.50%)		(29.00%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | U.S.
Sales by segment of business
Sales to customers	$ 37	61	$ 81	143
Percent Change (as a percent)	(40.20%)		(43.50%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | International
Sales by segment of business
Sales to customers	$ 64	78	$ 126	149
Percent Change (as a percent)	(17.60%)		(15.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 1,184	1,275	$ 2,344	2,620
Percent Change (as a percent)	(7.10%)		(10.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 837	902	$ 1,643	1,849
Percent Change (as a percent)	(7.20%)		(11.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 347	373	$ 701	771
Percent Change (as a percent)	(7.00%)		(9.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®
Sales by segment of business
Sales to customers	$ 559	549	$ 1,086	1,091
Percent Change (as a percent)	1.70%		(0.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.
Sales by segment of business
Sales to customers	$ 559	549	$ 1,086	1,091
Percent Change (as a percent)	1.70%		(0.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®
Sales by segment of business
Sales to customers	$ 179	177	$ 354	379
Percent Change (as a percent)	1.60%		(6.40%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.
Sales by segment of business
Sales to customers	$ 132	132	$ 249	286
Percent Change (as a percent)	(0.80%)		(13.00%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International
Sales by segment of business
Sales to customers	$ 47	43	$ 105	92
Percent Change (as a percent)	9.10%		14.10%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®
Sales by segment of business
Sales to customers	$ 136	183	$ 291	409
Percent Change (as a percent)	(25.60%)		(28.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.
Sales by segment of business
Sales to customers	$ 70	113	$ 146	261
Percent Change (as a percent)	(38.30%)		(44.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International
Sales by segment of business
Sales to customers	$ 66	70	$ 145	148
Percent Change (as a percent)	(5.00%)		(2.20%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION
Sales by segment of business
Sales to customers	$ 312	368	$ 614	$ 742
Percent Change (as a percent)	(15.30%)			(17.30%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | U.S.
Sales by segment of business
Sales to customers	$ 78	107	$ 163	$ 211
Percent Change (as a percent)	(27.70%)		(22.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | International
Sales by segment of business
Sales to customers	$ 234	260	$ 451	531
Percent Change (as a percent)	(10.20%)		(15.00%)
MEDICAL DEVICES
Sales by segment of business
Sales to customers	$ 4,288	6,489	$ 10,220	12,948
Percent Change (as a percent)	(33.90%)		(21.10%)
MEDICAL DEVICES | U.S.
Sales by segment of business
Sales to customers	$ 1,862	3,083	$ 4,760	6,192
Percent Change (as a percent)	(39.60%)		(23.10%)
MEDICAL DEVICES | International
Sales by segment of business
Sales to customers	$ 2,426	3,406	$ 5,460	6,756
Percent Change (as a percent)	(28.80%)		(19.20%)
MEDICAL DEVICES | Interventional Solutions
Sales by segment of business
Sales to customers	$ 590	750	$ 1,317	1,482
Percent Change (as a percent)	(21.50%)		(11.20%)
MEDICAL DEVICES | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 255	366	$ 620	709
Percent Change (as a percent)	(30.50%)		(12.60%)
MEDICAL DEVICES | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 335	385	$ 697	774
Percent Change (as a percent)	(12.80%)		(9.90%)
MEDICAL DEVICES | Orthopaedics
Sales by segment of business
Sales to customers	$ 1,451	2,224	$ 3,489	4,428
Percent Change (as a percent)	(34.70%)		(21.20%)
MEDICAL DEVICES | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 869	1,331	$ 2,119	2,649
Percent Change (as a percent)	(34.70%)		(20.00%)
MEDICAL DEVICES | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 583	894	$ 1,371	1,779
Percent Change (as a percent)	(34.80%)		(22.90%)
MEDICAL DEVICES | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 226	364	$ 563	725
Percent Change (as a percent)	(37.80%)		(22.30%)
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 137	216	$ 343	429
Percent Change (as a percent)	(36.50%)		(20.10%)
MEDICAL DEVICES | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 88	147	$ 220	295
Percent Change (as a percent)	(39.80%)		(25.40%)
MEDICAL DEVICES | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 174	372	$ 517	741
Percent Change (as a percent)	(53.10%)		(30.10%)
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 108	218	$ 322	441
Percent Change (as a percent)	(50.50%)		(27.10%)
MEDICAL DEVICES | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 66	153	$ 196	299
Percent Change (as a percent)	(56.80%)		(34.60%)
MEDICAL DEVICES | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 553	672	$ 1,207	1,357
Percent Change (as a percent)	(17.80%)		(11.10%)
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 354	407	$ 761	824
Percent Change (as a percent)	(12.90%)		(7.60%)
MEDICAL DEVICES | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 198	265	$ 445	533
Percent Change (as a percent)	(25.20%)		(16.50%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 499	818	$ 1,202	1,606
Percent Change (as a percent)	(39.00%)		(25.10%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 270	490	$ 693	955
Percent Change (as a percent)	(45.00%)		(27.40%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 230	328	$ 510	651
Percent Change (as a percent)	(29.90%)		(21.70%)
MEDICAL DEVICES | Surgery
Sales by segment of business
Sales to customers	$ 1,551	2,353	$ 3,651	4,748
Percent Change (as a percent)	(34.10%)		(23.10%)
MEDICAL DEVICES | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 490	926	$ 1,334	1,927
Percent Change (as a percent)	(47.00%)		(30.80%)
MEDICAL DEVICES | Surgery | International
Sales by segment of business
Sales to customers	$ 1,060	1,427	$ 2,317	2,821
Percent Change (as a percent)	(25.70%)		(17.90%)
MEDICAL DEVICES | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 775	1,029	$ 1,723	2,009
Percent Change (as a percent)	(24.60%)		(14.20%)
MEDICAL DEVICES | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 277	396	$ 658	800
Percent Change (as a percent)	(30.00%)		(17.70%)
MEDICAL DEVICES | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 498	633	$ 1,065	1,209
Percent Change (as a percent)	(21.20%)		(11.90%)
MEDICAL DEVICES | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 775	1,325	$ 1,928	2,739
Percent Change (as a percent)	(41.50%)		(29.60%)
MEDICAL DEVICES | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 213	530	$ 676	1,127
Percent Change (as a percent)	(59.80%)		(40.00%)
MEDICAL DEVICES | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 562	794	$ 1,252	1,612
Percent Change (as a percent)	(29.20%)		(22.40%)
MEDICAL DEVICES | Vision
Sales by segment of business
Sales to customers	$ 695	1,161	$ 1,762	2,290
Percent Change (as a percent)	(40.10%)		(23.00%)
MEDICAL DEVICES | Vision | U.S.
Sales by segment of business
Sales to customers	$ 248	461	$ 687	907
Percent Change (as a percent)	(46.10%)		(24.20%)
MEDICAL DEVICES | Vision | International
Sales by segment of business
Sales to customers	$ 447	701	$ 1,075	1,383
Percent Change (as a percent)	(36.10%)		(22.30%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 554	842	$ 1,368	1,666
Percent Change (as a percent)	(34.10%)		(17.90%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 203	333	$ 549	654
Percent Change (as a percent)	(39.00%)		(16.10%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 352	509	$ 819	1,011
Percent Change (as a percent)	(30.90%)		(19.00%)
MEDICAL DEVICES | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 141	319	$ 394	624
Percent Change (as a percent)	(55.80%)		(36.80%)
MEDICAL DEVICES | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 45	128	$ 138	253
Percent Change (as a percent)	(64.60%)		(45.30%)
MEDICAL DEVICES | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 96	$ 191	$ 256	$ 371
Percent Change (as a percent)	(49.90%)		(31.00%)